Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Vitamin B6
Selected research topic
Bone, joint, and mobility
The confirmed comparison studies tested several ingredients together. They cannot isolate the effect of this ingredient.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 2
- Human comparison publications
- 1
- Publications needing review
- 0
Findings in the studies
BMD
- Comparison result:Results were mixed for this outcome.
Several ingredients were tested together, so this ingredient’s individual effect is unknown.
General population · Combination study · two yearsMeasurement and study conditions
- Controlled human study
- Randomized trial
- Ingredient combination
- General population
- Primary outcome
- Between-group comparison
- Timepoint: two years
- Study comparison: Combined folic acid, B12, B6, and riboflavin plus shared vitamin D versus active placebo plus shared
nonspine fracture risk
Other human research, including observational studies and reviews
- A change was reported, but the comparison could not be confirmed.
Several ingredients were tested together, so this ingredient’s individual effect is unknown.
Patient group · Combination studyMeasurement and study conditions
- Controlled human study
- Randomized trial
- Ingredient combination
- Patient group
- Outcome role not specified
- Timepoint: unspecified
- Study comparison: unspecified
Representative outcome and study details
Human studies reported mixed results for BMD.
combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · between-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
- Combination, formula, or class studies do not isolate this ingredient or establish synergy.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 14.9 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 90
Papers linked to this topic 2 · distinct papers 2 · papers with a confirmed human comparison 1 · papers needing additional review 0
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- BMD: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
- nonspine fracture risk: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
BMD
Results for this measurement were mixed; no consistent conclusion can be drawn.
Controlled study in people · Ingredient combination · General population
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
nonspine fracture risk
A change was reported, but the comparison could not be confirmed.
Controlled study in people · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No reviewed caution rules are available yet. Reported caution findings are shown below.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Cautions reported with another supplement or medication
These studies reported worsening outcomes, reduced absorption, or other cautions with combined use. They do not predict an individual's outcome.
IsoniazidInteractions with medications like isoniazid are mentioned as a cause of Vitamin B6 deficiency.
AntiepilepticsInteractions with certain antiepileptics are mentioned as a cause of Vitamin B6 deficiency.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
마그네슘In subjects with severe/extremely severe stress, the combination of magnesium and vitamin B6 resulted in a 24% greater improvement compared to magnesium alone (p=0.0203).